rs587781632
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
|
27257965 |
2016 |
rs80357243
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.
|
20516115 |
2010 |
rs80357243
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Does familial breast cancer and thymoma suggest a cancer syndrome? A family perspective.
|
26344711 |
2015 |
rs41293463
|
|
|
0.010 |
GeneticVariation |
BEFREE |
This association was much weaker with the same fragment bearing a missense mutation (M1775R) that has been identified in breast tumors.
|
10403822 |
1999 |
rs55680408
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We used large-scale genetic and clinical resources from the ENIGMA, CIMBA and BCAC consortia to assess pathogenicity of c.594-2A > C. The combined odds for causality considering case-control, segregation and breast tumor pathology information was 3.23 × 10<sup>-8</sup> Our data indicate that c.594-2A > C is always in cis with c.641A > G. The spliceogenic effect of c.[594-2A > C;641A > G] was characterized using RNA analysis of human samples and splicing minigenes.
|
27008870 |
2016 |
rs80357034
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Two genetic variants were initially classified as VUSs (c.1155C>T and c.5191C>A). c.1155C>T is not predicted to be deleterious in the prescreening portion of our assessment strategy. c.5191C>A, on the other hand, causes p.T1691K, which is predicted to have high deleterious probability because of significant structural alteration, a high deleterious score in the predictive programs and, clinically, triple negative characteristics in breast tumors.
|
22277901 |
2012 |
rs80357635
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The observation of BRCA2 -26 G/A 5'UTR polymorphism concomitant with the presence of methylation in the promoter region was novel and emerged as a strong candidate for susceptibility to sporadic breast tumors.
|
21092294 |
2010 |
rs1057517590
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Nonsense-mediated mRNA decay: terminating erroneous gene expression.
|
15145354 |
2004 |
rs1057518636
|
|
GA |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1060505051
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1131692162
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1555581104
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1555582520
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Nonsense-mediated mRNA decay: terminating erroneous gene expression.
|
15145354 |
2004 |
rs1555599208
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
|
27257965 |
2016 |
rs1800747
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs273898674
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
|
27257965 |
2016 |
rs28897672
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs28897696
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs397508940
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
|
27257965 |
2016 |
rs397508979
|
|
CGAAAAGTGAA |
0.700 |
CausalMutation |
CLINVAR |
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
|
27257965 |
2016 |
rs397508983
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
|
27257965 |
2016 |
rs397509160
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs397509173
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs398122630
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs41293465
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
|
27257965 |
2016 |